State of New Jersey Common Pension Fund D’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
N
PAM
State of New Jersey Common Pension Fund D's ACAD Position: Q2 2026 in Review
State of New Jersey Common Pension Fund D reduced its Acadia Pharmaceuticals (ACAD) stake by 8.1% in Q2 2026, selling an estimated $71.8K and leaving 37,211 shares worth $941K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.
State of New Jersey Common Pension Fund D first reported a position in ACAD in Q3 2019 and has held it in 23 quarters since. The position peaked at $4.38M in Q4 2020. 175 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.
- State of New Jersey Common Pension Fund D held 37,211 shares of Acadia Pharmaceuticals worth $941K as of Q2 2026.
- State of New Jersey Common Pension Fund D sold 3,262 Acadia Pharmaceuticals shares in Q2 2026, an estimated $71.8K.
- Acadia Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1552 holding.
- State of New Jersey Common Pension Fund D first reported a position in Acadia Pharmaceuticals in Q3 2019 and has held it in 23 quarters since.
- State of New Jersey Common Pension Fund D's Acadia Pharmaceuticals position peaked at $4.38M in Q4 2020.
- 175 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.